-
Je něco špatně v tomto záznamu ?
CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination
J Falck, JV Forment, J Coates, M Mistrik, J Lukas, J Bartek, SP Jackson
Jazyk angličtina Země Anglie, Velká Británie
NLK
Free Medical Journals
od 2000 do Před 1 rokem
PubMed Central
od 2000
Europe PubMed Central
od 2000 do Před 1 rokem
ProQuest Central
od 2000-07-15 do 2013-11-30
Open Access Digital Library
od 2000-07-01
Medline Complete (EBSCOhost)
od 2000-07-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-07-15 do 2013-11-30
Public Health Database (ProQuest)
od 2000-07-15 do 2013-11-30
Wiley Free Content
od 2000 do Před 1 rokem
PubMed
22565321
DOI
10.1038/embor.2012.58
Knihovny.cz E-zdroje
- MeSH
- DNA vazebné proteiny chemie MeSH
- dvouřetězcové zlomy DNA MeSH
- enzymy opravy DNA chemie MeSH
- homologní rekombinace * MeSH
- jaderné proteiny * genetika metabolismus MeSH
- lidé MeSH
- mutageneze cílená MeSH
- nádorové buněčné linie MeSH
- oprava DNA MeSH
- proteinkinasa CDC2 * chemie metabolismus MeSH
- proteiny buněčného cyklu * chemie genetika metabolismus MeSH
- replikace DNA * MeSH
- štěpení DNA * MeSH
- substituce aminokyselin MeSH
- Check Tag
- lidé MeSH
The conserved MRE11-RAD50-NBS1 (MRN) complex is an important sensor of DNA double-strand breaks (DSBs) and facilitates DNA repair by homologous recombination (HR) and end joining. Here, we identify NBS1 as a target of cyclin-dependent kinase (CDK) phosphorylation. We show that NBS1 serine 432 phosphorylation occurs in the S, G2 and M phases of the cell cycle and requires CDK activity. This modification stimulates MRN-dependent conversion of DSBs into structures that are substrates for repair by HR. Impairment of NBS1 phosphorylation not only negatively affects DSB repair by HR, but also prevents resumption of DNA replication after replication-fork stalling. Thus, CDK-mediated NBS1 phosphorylation defines a molecular switch that controls the choice of repair mode for DSBs.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14072956
- 003
- CZ-PrNML
- 005
- 20140925175350.0
- 007
- ta
- 008
- 140925s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/embor.2012.58 $2 doi
- 035 __
- $a (PubMed)22565321
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Falck, J. $u Department of Biochemistry, Wellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge, UK.
- 245 10
- $a CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination / $c J Falck, JV Forment, J Coates, M Mistrik, J Lukas, J Bartek, SP Jackson
- 504 __
- $a Literatura
- 520 9_
- $a The conserved MRE11-RAD50-NBS1 (MRN) complex is an important sensor of DNA double-strand breaks (DSBs) and facilitates DNA repair by homologous recombination (HR) and end joining. Here, we identify NBS1 as a target of cyclin-dependent kinase (CDK) phosphorylation. We show that NBS1 serine 432 phosphorylation occurs in the S, G2 and M phases of the cell cycle and requires CDK activity. This modification stimulates MRN-dependent conversion of DSBs into structures that are substrates for repair by HR. Impairment of NBS1 phosphorylation not only negatively affects DSB repair by HR, but also prevents resumption of DNA replication after replication-fork stalling. Thus, CDK-mediated NBS1 phosphorylation defines a molecular switch that controls the choice of repair mode for DSBs.
- 536 __
- $c Grant Number: 092096 (United Kingdom Wellcome Trust)
- 536 __
- $c Grant Number: 11224 (United Kingdom Cancer Research UK)
- 536 __
- $c Grant Number: 268536 (International European Research Council)
- 536 __
- $c Grant Number: A11224 (United Kingdom Cancer Research UK)
- 536 __
- $c Grant Number: C6/A11224 (United Kingdom Cancer Research UK)
- 536 __
- $c Grant Number: (United Kingdom Wellcome Trust)
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a substituce aminokyselin $7 D019943
- 650 02
- $a proteinkinasa CDC2 $x chemie $7 D016203
- 650 12
- $a proteinkinasa CDC2 $x metabolismus $7 D016203
- 650 02
- $a proteiny buněčného cyklu $x chemie $7 D018797
- 650 02
- $a proteiny buněčného cyklu $x genetika $7 D018797
- 650 12
- $a proteiny buněčného cyklu $x metabolismus $7 D018797
- 650 02
- $a nádorové buněčné linie $7 D045744
- 650 02
- $a dvouřetězcové zlomy DNA $7 D053903
- 650 12
- $a štěpení DNA $7 D053837
- 650 02
- $a oprava DNA $7 D004260
- 650 02
- $a enzymy opravy DNA $x chemie $7 D045643
- 650 12
- $a replikace DNA $7 D004261
- 650 02
- $a DNA vazebné proteiny $x chemie $7 D004268
- 650 12
- $a homologní rekombinace $7 D059765
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mutageneze cílená $7 D016297
- 650 02
- $a Nuclear Proteins $x ch [Chemistry]
- 650 02
- $a jaderné proteiny $x genetika $7 D009687
- 650 12
- $a jaderné proteiny $x metabolismus $7 D009687
- 650 02
- $a Phosphorylation
- 650 02
- $a Protein Processing, Post-Translational
- 650 02
- $a Serine $x ge [Genetics]
- 650 02
- $a Serine $x me [Metabolism]
- 700 1_
- $a Forment, J.V.
- 700 1_
- $a Coates, J.
- 700 1_
- $a Mistrik, M.
- 700 1_
- $a Lukáš, Jiří $7 xx0094305
- 700 1_
- $a Bártek, Jiří, $d 1953- $7 xx0046271
- 700 1_
- $a Jackson, S.P.
- 773 0_
- $t EMBO Reports $g Roč. 13, č. 6 (2012), s. 561-568 $p EMBO Rep $x 1469-221X $w MED00006590
- 773 0_
- $p EMBO Rep $g 13(6):561-8, 2012 Jun
- 910 __
- $a ABA008 $y 4 $z 0
- 990 __
- $a 20140925175817 $b ABA008
- 991 __
- $a 20140925175817 $b ABA008
- 999 __
- $a ok $b bmc $g 1040848 $s 871853
- BAS __
- $a 3
- BMC __
- $a 2012 $b 13 $c 6 $d 561-568 $i 1469-221X $m Embo reports $x MED00006590 $n EMBO Rep
- LZP __
- $a NLK 2014-1/lp